Investegate |Junshi Biosciences Announcements | Junshi Biosc

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of Adalimumab Injection

Related Keywords

Guangzhou , Guangdong , China , Beijing , Maryland , United States , Shanghai , Suzhou , Jiangsu , San Francisco , California , Chinese , Datao Liu , Junshi Bioscience , Junshi Biosciences , Zhi Li , Mabwell Biosciences , Mabwell Bioscience , Ir Team , Pr Team , National Medical Products Administration , Institute Of Microbiology The Chinese Academy , Mabwell Shanghai Bioscience Co Ltd , Shanghai Junshi Biosciences Co Ltd , Junshi Biosciences Announces Approval , Supplemental Application , Additional Indications , Healthy China Innitiative , Plaque Psoriasis , Chinese Academy , Emergency Use Authorizations , Investegate Announcements , Investegate Company Announcements , Lobenewswire , Lobenewswire And Globenewswire , Nw ,